The University of Texas, MD Anderson Cancer Center — Houston, Texas

The University of Texas, MD Anderson Cancer Center is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Texas, MD Anderson Cancer Center has participated in 32 clinical trials with 10 currently active.

Therapeutic areas: Head and Neck Squamous Cell Carcinoma, Acute Myeloid Leukemia, Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive.

Sponsors: Gilead Sciences, Pfizer, Pharmacyclics LLC..

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Texas, MD Anderson Cancer Center?

The University of Texas, MD Anderson Cancer Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Texas, MD Anderson Cancer Center conducted?

The University of Texas, MD Anderson Cancer Center has 32 clinical trials on record, with 10 currently active. Their work covers Head and Neck Squamous Cell Carcinoma, Acute Myeloid Leukemia, Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive.

Is The University of Texas, MD Anderson Cancer Center accredited by Crixeo Health?

Yes — The University of Texas, MD Anderson Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The University of Texas, MD Anderson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.